Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Graham

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Molecular Therapy. Nucleic Acids|May 1, 2013
A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and HumansNicholas R Jones, Melissa A Pegues, Mark A McCrory, et al.
Plos One|August 10, 2017
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm developmentSeonwook Kim, Lihua Yang, Seongu Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2019
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) ReceptorsNatalie C Kegulian, Bastian Ramms, Steven Horton, et al.
The Journal of Clinical Investigation|October 28, 2014
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemiaDavid G Cotter, Baris Ercal, Xiaojing Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 29, 2021
Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathyAlan D Attie, Kathryn M Schueler, Mark P Keller, et al.
The New England Journal of Medicine|December 4, 2014
Targeting APOC3 in the familial chylomicronemia syndromeDaniel Gaudet, Diane Brisson, Karine Tremblay, et al.
Cell Metabolism|February 5, 2015
MAFG is a transcriptional repressor of bile acid synthesis and metabolismThomas Q de Aguiar Vallim, Elizabeth J Tarling, Hannah Ahn, et al.
The Journal of Biological Chemistry|September 13, 2014
Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceNisreen Soufi, Angela M Hall, Zhouji Chen, et al.
Journal of Lipid Research|December 13, 2016
The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosisDaniel Ferguson, Jun Zhang, Matthew A Davis, et al.
The Journal of Biological Chemistry|October 30, 2015
Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and InflammationXiaowei Sun, Mary E Haas, Ji Miao, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Molecular Therapy. Nucleic Acids|May 1, 2013
A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and HumansNicholas R Jones, Melissa A Pegues, Mark A McCrory, et al.
Plos One|August 10, 2017
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm developmentSeonwook Kim, Lihua Yang, Seongu Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2019
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) ReceptorsNatalie C Kegulian, Bastian Ramms, Steven Horton, et al.
The Journal of Clinical Investigation|October 28, 2014
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemiaDavid G Cotter, Baris Ercal, Xiaojing Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 29, 2021
Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathyAlan D Attie, Kathryn M Schueler, Mark P Keller, et al.
The New England Journal of Medicine|December 4, 2014
Targeting APOC3 in the familial chylomicronemia syndromeDaniel Gaudet, Diane Brisson, Karine Tremblay, et al.
Cell Metabolism|February 5, 2015
MAFG is a transcriptional repressor of bile acid synthesis and metabolismThomas Q de Aguiar Vallim, Elizabeth J Tarling, Hannah Ahn, et al.
The Journal of Biological Chemistry|September 13, 2014
Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceNisreen Soufi, Angela M Hall, Zhouji Chen, et al.
Journal of Lipid Research|December 13, 2016
The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosisDaniel Ferguson, Jun Zhang, Matthew A Davis, et al.
The Journal of Biological Chemistry|October 30, 2015
Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and InflammationXiaowei Sun, Mary E Haas, Ji Miao, et al.
Pageof 14